Development and validation of an 18F-FDG PET/CT radiomic nomogram for predicting axillary lymph-node status after neoadjuvant chemotherapy for breast cancer: a multicenter study
Authors:
Open Access
- 17 August 2025
- journal article
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 39 (12) , 1326-1336
Abstract
Rationale and objective: To develop and validate the predictive value of 18 F-FDG PET/CT radiomics models based on data preprocessing methods for axillary lymph-node (ALN) status after neoadjuvant chemotherapy (NAC) for breast cancer. Materials and methods: According to the status of ALN after NAC, we divided the breast cancer patients of the three scanners into the pathological complete remission (pCR) and non-pCR groups, respectively. Totally 630 models were obtained based on various data preprocessing, feature filtering, and modeling approaches. On the one hand, different data preprocessing methods were compared to analyze the advantages of different preprocessing methods. On the other hand, the AUC of predicting ALN status was compared among all models, and the model with the best prediction was obtained. Finally, the optimal model is combined with the clinical and the corresponding Nomogram is plotted. Results: The comparison of the data preprocessing modalities revealed that the model prediction of tumor-to-liver ratio (TLR) radiomics was better than origin radiomics (OR), and the effect of Combat and Limma was better than without batch effects. All preprocessing modalities could be used as a potential method that can further optimize the model. The optimal model had a predicted AUC of 0.798 for ALN status after NAC for breast cancer in the test set and an AUC of 0.811 when combined with clinical characteristics. Conclusion: It is necessary to pre-process the data before conducting a study on multicenter data, and the model developed in this way can effectively predict the status of ALN after NAC in breast cancer.Keywords
This publication has 45 references indexed in Scilit:
- 18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the ArtCurrent Radiopharmaceuticals, 2020
- PET/CT in radiation oncologySeminars in Oncology, 2019
- Which of the fluorine-18 fluorodeoxyglucose positron emission tomography/computerized tomography parameters are better associated with prognostic factors in breast cancer?Medicine, 2019
- Radiomics: the facts and the challenges of image analysisEuropean Radiology Experimental, 2018
- The prognostic value of SUVmax measuring on primary lesion and ALN by 18F-FDG PET or PET/CT in patients with breast cancerEuropean Journal of Radiology, 2018
- Elevated tumor-to-liver uptake ratio (TLR) from 18F–FDG-PET/CT predicts poor prognosis in stage IIA colorectal cancer following curative resectionEuropean Journal of Nuclear Medicine and Molecular Imaging, 2017
- Neoadjuvant Chemotherapy and Surgical Management of the Axilla in Breast Cancer: A Review of Current Data2015
- Tumor SUVmax Normalized to Liver Uptake on 18F-FDG PET/CT Predicts the Pathologic Complete Response After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal CancerNuclear Medicine and Molecular Imaging, 2014
- Surgical margins of resection for breast cancer: current evidence.2012
- Predictive value of ¹⁸F-fluorodeoxyglucose PET/CT for transarterial chemolipiodolization of hepatocellular carcinoma.World Journal of Gastroenterology, 2012